Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

PKC

PKC (protein kinase C) is a serine/threonine protein kinase that mediates insulin signaling, actin cytoskeleton, cell mobility, apoptosis and tumorigenesis etc.

Items 1-10 of 49

Page
per page
  1. Enzastaurin (LY317615)
    A1670 Enzastaurin (LY317615)
     2 Citation
    Target: PKC
    Summary: PKC beta inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL
  2. Zoledronic Acid
    A1352 Zoledronic Acid
    Target: Farnesyl Diphosphate Synthases
    Summary: Potent nitrogen-containing bisphosphonates
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  3. Go 6976
    A8341 Go 6976
    Target: PKC
    Summary: PKCα/PKCβ1 inhibitor
      ≥15.77 mg/mL
  4. GF 109203X
    A8342 GF 109203X
     1 Citation
    Target: PKC
    Summary: Protein kinase C,MLCK,PKG and PKA inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL
  5. Go 6983
    A8343 Go 6983
     1 Citation
    Summary: pan-PKC inhibitor
      ≥22.15 mg/mL
  6. K-252c
    A8344 K-252c
    Target: PKC|PKA
    Summary: Protein kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.55 mg/mL
  7. Sotrastaurin (AEB071)
    A8525 Sotrastaurin (AEB071)
    Target: PKC
    Summary: PKC inhibitor
      ≥21.9 mg/mL
  8. ZIP (SCRAMBLED)
    A8830 ZIP (SCRAMBLED)
    Summary: PKMζ inhibitor
      ≥192.8 mg/mL
  9. Midostaurin (PKC412)
    B3709 Midostaurin (PKC412)
    Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB
    Summary: PKC inhibitor
      ≥57.1 mg/mL
  10. D-erythro-Sphingosine (synthetic)
    B6385 D-erythro-Sphingosine (synthetic)
    Summary: protein kinase C and calmodulin-dependent enzymes inhibitor

Items 1-10 of 49

Page
per page